IP Library Granted Patent US 11,008,593
Granted Patent B2
US 11,008,593 · App. 16/195,566 · Granted May 18, 2021

Process for producing 1,3-propanediol compound

Inventors: Klaas Jan Hellingwerf (Amsterdam, NL); Maarten Joost Teixeira De Mattos (Amsterdam, NL)
C12P7/56C12N1/20C12N15/74C12N15/82C12P5/026C12P7/04C12P7/06C12P7/065C12P7/16C12P7/18C12P7/20C12P7/24C12P7/28C12P7/30Y02E50/10
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,008,593
App. No.
16/195,566
Granted
May 18, 2021
Kind
B2
Abstract

A process of producing an organic compound and/or an intermediary compound as defined herein by feeding carbon dioxide to a culture of a cyanobacterial cell and subjecting said culture to light, wherein said cell is capable of expressing a nucleic acid molecule, wherein the expression of said nucleic acid molecule confer on the cell the ability to convert a glycolytic intermediate into said organic compound and/or into said intermediary compound and wherein said nucleic acid molecule is under the control of a regulatory system which responds to a change in the concentration of a nutrient in said culture.

Claims (15)

1. A process of producing 1,3-propanediol compound, comprising:

feeding carbon dioxide to a culture of Cyanobacterial cells; and

subjecting the culture to light,

wherein the cell expresses a nucleic acid molecule and expression of the nucleic acid molecule confers an ability to convert a glycolytic intermediate into 1,3-propanediol, wherein said nucleic acid molecule is under the control of a regulatory system which responds to a change in the concentration of a nutrient in said culture, wherein the glycolytic intermediate is hydroxypropionaldehyde, wherein said nucleic acid molecule encodes an enzyme that converts glyceraldehyde-3-phosphate to 1,3-propanediol, wherein said enzyme is glycerol dehydratase, and wherein the glycerol dehydratase has an amino acid sequence that is at least 95% identical to SEQ ID NO: 31 or is encoded by a polynucleotide sequence that is at least 95% identical to SEQ ID NO: 32.

2. The process of claim 1 , wherein said enzyme is not sensitive to oxygen inactivation.

3. The process of claim 1 , wherein the regulatory system responds to a change in the concentration of the nutrient ammonium in said culture.

4. The process of claim 1 , wherein the 1,3-propanediol compound or glycolytic intermediate is separated from the culture.

5. A Cyanobacterial cell that expresses a nucleic acid molecule, wherein expression of the nucleic acid molecule allows the Cyanobacterial cell to convert a glycolytic intermediate into 1,3-propanediol, wherein the nucleic acid molecule is under the control of a regulatory system which responds to a change in the concentration of a nutrient when culturing said Cyanobacterial cell, wherein the glycolytic intermediate is hydroxypropionaldehyde, wherein said nucleic acid molecule encodes an enzyme that converts glyceraldehyde-3-phosphate to 1,3-propanediol, wherein said enzyme is a glycerol dehydratase, and wherein the glycerol dehydratase has an amino acid sequence that is at least 95% identical to SEQ ID NO: 31 or is encoded by a polynucleotide sequence that is at least 95% identical to SEQ ID NO: 32.

6. The Cyanobacterial cell of claim 5 , wherein the regulatory system responds to a change in the concentration of the nutrient ammonium.

7. The process of claim 1 , wherein the Cyanobacterial cell is obtained from a Synechocystis cell.

8. The process of claim 1 , wherein the Cyanobacterial cell is obtained from a Synechocystis PCC 6083 cell.

9. The Cyanobacterial cell of claim 5 , wherein the Cyanobacterial cell is obtained from a Synechocystis cell.

10. The Cyanobacterial cell of claim 5 , wherein the Cyanobacterial cell is obtained from a Synechocystis PCC 6083 cell.

11. The process of claim 1 , wherein the nucleic acid molecule comprised in the cell is integrated into its genome by homologous recombination.

12. The Cyanobacterial cell of claim 5 , wherein the nucleic acid molecule comprised in the Cyanobacterial cell is integrated into its genome by homologous recombination.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 13, 2021
From: TEIXEIRA DE MATTOS, MAARTEN JOOST; HELLINGWERF, KLAAS JAN
To: UNIVERSITEIT VAN AMSTERDAM
Reel/Frame 055902/0855 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 13, 2021
From: UNIVERSITEIT VAN AMSTERDAM
To: PHOTANOL BV.
Reel/Frame 055902/0886 →
Priority Claims (1)
EP 07123340 · Dec 17, 2007 · regional
Continuity (4)
Continuation 14956470 · Dec 2, 2015
Division 12808480
Provisional Application 61014092 · Dec 17, 2007
Related Publication 20190177752A1 · Jun 13, 2019